How to boost enrollment of Black, Hispanic patients in pediatric clinical trials: Newsroom

To ensure the best web experience, please upgrade to the latest standard browser for your computer. The findings, published in JAMA Network Open, focused on parent and clinician perspectives, revealing opportunities to increase clinical trial participation for historically marginalized patients to help improve outcomes.

Efforts to address these gaps include increasing participation in clinical trials, which provide access to new therapies and help ensure findings apply broadly across patient populations. Department of Health and Human Services that sampled National Institutes of Health-funded clinical trials found that most of.

What Happened

Despite the importance of clinical trial participation, there is limited data on the perspectives of Black and Hispanic families related to involvement. To better understand these views, researchers surveyed 60 parents of Black and Hispanic children with cancer and 15 clinicians from.

• As of January 8, 2016, the standard browser for UT Southwestern will be IE 11.

• DALLAS – July 31, 2026 – While Black and Hispanic families are enthusiastic about research participation, other provider- and systems-focused factors may influence their involvement in pediatric oncology clinical trials, a UT Southwestern Medical.

• While survival rates for children with cancer have drastically improved from 10% to 85% over the past 75 years, research suggests disparities persist, with Black and Hispanic children continuing to have lower survival rates.

Key Details

Using surveys from all participants and interviews with a subset of 20 participating parents and the 15 clinicians, researchers identified factors that facilitated clinical trial participation as well as those that acted as barriers. Two key factors that both parents and clinicians.

• About 73% of participating families reported experiencing household material hardship, which includes insecurity with food, housing, transportation, or utilities.

• The full-time faculty of nearly 3,400 is responsible for groundbreaking medical advances and is committed to translating science-driven research quickly to new clinical treatments.

• UT Southwestern physicians in more than 80 specialties care for more than 143,000 hospitalized patients, attend to more than 470,000 emergency room cases, and oversee nearly 5.3 million outpatient visits a year.

Why It Matters

Notably, a majority of parents reported very high levels of trust in their oncology team. When it came to barriers for participation, parents and clinicians cited the informed consent discussion required for trial participation and difficult-to-understand trial materials.

• The institution’s faculty members have received six Nobel Prizes and include 28 members of the National Academy of Sciences, 26 members of the National Academy of Medicine, and 14 Howard Hughes Medical Institute Investigators.

• UT Southwestern, one of the nation’s premier academic medical centers, integrates pioneering biomedical research with exceptional clinical care and education.

What Reports Say

Coverage of the story so far points to:

• Continued reporting by UT Southwestern as more details emerge